The ANKRD54 Knockout A-549 Polyclonal Cells constitute a polyclonal knockout cell population generated from the human A-549 lung adenocarcinoma epithelial cell line through CRISPR/Cas9-mediated disruption of the ANKRD54 gene. This loss-of-function model enables researchers to investigate the functional consequences of ANKRD54 depletion in a cancer-relevant context. The polyclonal nature of the product ensures a heterogeneous representation of knockout events, avoiding clonal artifacts and providing a robust system for studying gene function at the population level.
The A-549 cell line is an established model of human lung adenocarcinoma, originally derived from a 58-year-old male patient. These cells exhibit characteristics of alveolar type II epithelial cells, including the presence of lamellar bodies and surfactant production, and are widely employed in cancer biology, drug testing, and metastasis research. Their adherent epithelial morphology and well-characterized signaling networks make them a versatile platform for investigating the molecular underpinnings of lung cancer progression.
ANKRD54 encodes a critical component of the linker of nucleoskeleton and cytoskeleton (LINC) complex, where it mediates physical coupling between the nuclear lamina and the actin cytoskeleton. Specifically, ANKRD54 interacts with SUN1 and SUN2 in the inner nuclear membrane and with nesprins (SYNE1 and SYNE2) in the outer nuclear membrane, bridging to lamin A/C (LMNA). This molecular architecture is essential for nuclear positioning, mechanotransduction, and force transmission. Upstream, ANKRD54 function is regulated by mechanical stress, integrin-mediated adhesion signaling, and extracellular matrix stiffness. Downstream, it influences actin cytoskeleton remodeling, nuclear morphology, and focal adhesion dynamics, thereby affecting cell migration and mechanical homeostasis.
In the A-549 lung adenocarcinoma context, ANKRD54 knockout provides a physiologically relevant system to dissect the role of LINC complex-mediated mechanotransduction in cancer cell behavior. Aberrant nuclear mechanics and altered cell migration are hallmarks of metastatic progression, and disrupting ANKRD54 is expected to impair nuclear-cytoskeletal connectivity, potentially affecting invasive capacity and response to mechanical cues. This model is therefore valuable for studying the contribution of nuclear envelope proteins to lung adenocarcinoma aggressiveness and for screening therapeutics targeting mechanosignaling pathways.
Researchers can employ this polyclonal knockout cell population in a variety of assays to explore nuclear mechanics and migration. Immunofluorescence staining for nuclear morphology and LINC complex components (e.g., SUN1, SYNE1, LMNA) can be combined with quantitative image analysis. Functional assays such as wound healing and cell migration assays, traction force microscopy to measure cellular forces, and cell adhesion assays are directly applicable. Western blotting enables confirmation of LINC complex integrity. These tools support investigations into nuclear mechanobiology, cancer invasion, and the mechanistic basis of mechanotransduction. For further technical details or to place an order, please contact Ascent Research.
